Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
GI Dynamics says another 5 centers in Europe are offering its EndoBarrier weight-loss device for treating obesity and Type II diabetes. GI Dynamics (ASX:GID) said another 5 medical centers in Europe are online with its EndoBarrier weight loss and diabetes device. The Lexington, Mass.-based medical device company said centers in Spain, Switzerland and 3 in Germany are now implanting the device, a gut liner designed to inhibit the uptake of nutrients from food.
Help employers find you! Check out all the jobs and post your resume.